Central nervous system tumors and organ donation: An update

Current Opinion in Organ Transplantation

Volumn 11, Issue 2, 2006, Pages 146-150

  Finger, Erik B ^a   Feng, Sandy ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Surgery   (United States)

Author keywords

Central nervous system tumor; Metastasis; Organ donation

Indexed keywords

ANAMNESIS; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID SHUNTING; DATA BASE; DISEASE SEVERITY; DISEASE TRANSMISSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NEUROSURGERY; ORGAN DONOR; ORGAN TRANSPLANTATION; RECIPIENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

EID: 33645825436     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000218927.89278.c7     Document Type: Review

References (37)

1. UNOS: United Network for Organ Sharing. November 2005.
2. Lopez-Navidad A, Caballero F. Extended criteria for organ acceptance: strategies for achieving organ safety and for increasing organ pool. Clin Transplant 2003; 17:308-324.
3. Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002; 2:701-711.
4. DeAngelis LM. Brain tumors. N Engl J Med 2001; 344:114-123.
5. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors. Transplantation 2002; 73:579-582.
6. Collins VP. Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry 2004; 75 Suppl 2:ii2-11.
7. Detry O, Honore P, Hans MF, Delbouille MH, Jacquet N, Meurisse M. Organ donors with primary central nervous system tumor. Transplantation 2000; 70:244-248; discussion 251-242.
8. Subramanian A, Harris A, Piggott K, Shieff C, Bradford R. Metastasis to and from the central nervous system - the 'relatively protected site'. Lancet Oncol 2002; 3:498-507.
9. Sklar CA. Childhood brain tumors. J Pediatr Endocrinol Metab 2002; 15 (Suppl 2):669-673.
10. Bailey P, Cushing H. A classification of tumours of the glioma group on a histogenetic basis with a correlated study of prognosis. Philadelphia: JB Lippincott; 1926.
11. Hoffman HJ, Duffner PK. Extraneural metastases of central nervous system tumors. Cancer 1985; 56:1778-1782.
12. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000; 70:1747-1751.
13. Lefrancois N, Touraine JL, Cantarovich D, et al. Transmission of medulloblastoma from cadaver donor to three organ transplant recipients. Transplant Proc 1987; 19:2242.
14. Morse JH, Turcotte JG, Merion RM, Campbell DA Jr, Burtch GD, Lucey MR. Development of a malignant tumor in a liver transplant graft procured from a donor with a cerebral neoplasm. Transplantation 1990; 50:875-877.
15. Val-Bernal F, Ruiz JC, Cotorruelo JG, Arias M. Glioblastoma multiforme of donor origin after renal transplantation: report of a case. Hum Pathol 1993; 24:1256-1259.
16. Ruiz JC, Cotorruelo JG, Tudela V, et al. Transmission of glioblastoma multiforme to two kidney transplant recipients from the same donor in the absence of ventricular shunt. Transplantation 1993; 55:682-683.
17. Konigsrainer A, Steurer W, Schumer J, et al. Transmission of non-Hodgkin's lymphoma through renal allografts - disastrous result of false diagnosis and inadequate information. Transplant Proc 1993; 25:3075-3076.
18. Colquhoun SD, Robert ME, Shaked A, et al. Transmission of CNS malignancy by organ transplantation. Transplantation 1994; 57:970-974.
19. Jonas S, Bechstein WO, Lemmens HP, Neuhaus R, Thalmann U, Neuhaus P. Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int 1996; 9:426-429.
20. Bosmans JL, Ysebaert D, De Cock AM, et al. Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: a case report. Transplant Proc 1997; 29:838.
21. Frank S, Muller J, Bonk C, Haroske G, Schackert HK, Schackert G. Transmission of glioblastoma multiforme through liver transplantation. Lancet 1998; 352:31. Erratum in: Lancet 1998; 352:1316.
22. Punnett AS, McCarthy LJ, Dirks PB, Hawkins C, Bouffet E. Patients with primary brain tumors as organ donors: case report and review of the literature. Pediatr Blood Cancer 2004; 43:73-77. An informative recent review of existing case reports, donor series and registry data on the risks of tumor transmission from organ donors with CNS tumors.
23. Hornik L, Tenderich G, Wlost S, Zittermann A, Minami K, Koerfer R. Organs from donors with primary brain malignancy: the fate of cardiac allograft recipients. Transplant Proc 2004; 36:3133-3137. Summarizes a case series of 32 cardiac allograft recipients receiving organs from donors with primary CNS tumors without evidence of donor-derived tumor transmission.
24. Chui AK, Herbertt K, Wang LS, et al. Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report. Transplant Proc 1999; 31:1266-1267.
25. Kauffman HM. The United Network for Organ Sharing position on using donors with primary central nervous system malignancies. Transplantation 2005; 79:622-623. A brief update of the UNOS data on the frequency of CNS tumor transmission to organ recipients and a clarification of the author's position on the risks of transmission in organ transplantation.
26. Buell JF, Trofe J, Sethuraman G, et al. Donors with central nervous system malignancies: are they truly safe? Transplantation 2003; 76:340-343.
27. Pokorna E, Vitko S. The fate of recipients of organs from donors with diagnosis of primary brain tumor. Transpl Int 2001; 14:346-347.
28. Schiff D. Which donors with brain tumors are safe? Transplantation 2004; 77:1906; author reply 1906-1907. Interesting commentary on the validity of the IPITTR registry data and rebuttal from a representative of the registry that updates the registry data and re-interprets the results as classified by WHO brain tumor criteria.
29. Buell JF, Gross T, Alloway RR, Trofe J, Woodle ES. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc 2005; 37:583-584. An excellent brief report of the high risk of tumor transmission to allograft recipients when metastatic lesions to the potential organ donor's brain are misdiagnosed as primary CNS tumors or non-neoplastic processes.
30. Bell D, Grant R, Collie D, Walker M, Whittle IR. How well do radiologists diagnose intracerebral tumour histology on CT? Findings from a prospective multicentre study. Br J Neurosurg 2002; 16:573-577.
31. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Am J Neuroradiol 2004; 25:214-221.
32. Asari S, Makabe T, Katayama S, Itoh T, Tsuchida S, Ohmoto T. Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology 1994; 36:308-310.
33. Asari S, Makabe T, Katayama S, et al. Evaluation of MRI score in the differentiation between glioblastoma multiforme and metastatic adenocarcinoma of the brain. Acta Neurochir (Wien) 1993; 122:54-59.
34. Cha S. Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 2004; 15:279-289.
35. McGirt MJ, Villavicencio AT, Bulsara KR, Friedman AH. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol 2003; 59:277-281; discussion 281-272.
36. Prayson RA, Agamanolis DP, Cohen ML, et al. Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci 2000; 175:33-39.
37. Glotsos D, Spyridonos P, Petalas P, et al. Computer-based malignancy grading of astrocytomas employing a support vector machine classifier, the WHO grading system and the regular hematoxylin-eosin diagnostic staining procedure. Anal Quant Cytol Histol 2004; 26:77-83.